Home Tools
Log in
Cart

Search Result

Search Results for " alk tyrosine kinase receptor "

20

Compounds

Cat No. Product Name Synonyms Targets
T6409 ALK kinase inhibitor-1 SAR348830 Others
SAR348830 is an ALK inhibitor, targeting anaplastic lymphoma kinase.
T3041 ALK inhibitor 2 FAK , ALK
ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.
T10285 ALK inhibitor 1 FAK , IGF-1R , ALK
ALK inhibitor 1 is a selective ALK kinase inhibitor.
T1967 AZD-3463 ALK/IGF1R inhibitor Apoptosis , IGF-1R , ALK , Autophagy
AZD-3463 (ALK/IGF1R inhibitor) , an orally bioavailable ALK inhibitor (Ki: 0.75 nM), can inhibit IGF1R with equivalent potency.
T3079 GSK1838705A IGF-1R , JNK , S6 Kinase , ALK
GSK1838705A is an effective IGF-1R inhibitor (IC50: 2.0 nM), modestly potent to IR (IC50: 1.6 nM) and ALK (IC50: 0.5 nM), respectively, and little inhibition to other protein kinases.
T8152 6-Demethoxytangeretin MAPK , ALK
6-Demethoxytangeretin is a citrus flavonoid isolated from Citrus depressa.
T15612 JH-VIII-157-02 Microtubule Associated , ALK
JH-VIII-157-02 is an inhibitor of ALK and inhibits echinoderm microtubule-associated protein-like 4-ALK (EML4-ALK) with IC50s of 2 nM for EML4-ALK G1202R, EML4-ALKwt, EML4-ALK C1156Y, EML4-ALK F1174L, and EML4-ALK F1174L...
T11254 F-1 ROS , ALK , ROS Kinase
F-1 is IC50s of 2.1 nM, 2.3 nM, 1.3 nM and 3.9 nM for ALKWT, ROS1WT, ALKL1196M and ALKG1202R, respectively. F-1 is a potent ALK and ROS1 dual inhibitor, suppresses phospho-ALK and its relative downstream signaling pathwa...
T2612 CEP-28122 ALK
CEP-28122 is a highly potent and selective orally active ALK inhibitor.
T4257 Belizatinib TSR-011 Trk receptor , ALK
Belizatinib (TSR-011) is an effective, oral and dual inhibitor of ALK (IC50: 0.7 nM, wild-type recombinant ALK) and TRKA, TRKB, and TRKC.
T16153 MS4078 ALK , Ligand for E3 Ligase
MS4078 is an inhibitor and aplastic lymphoma kinase (ALK) PROTAC (degrader) based on Cereblon ligand, with a Kd of 19 nM for binding affinity to ALK.
T3059 ALK-IN-1 AP26113,Brigatinib,AP26113-analog EGFR , IGF-1R , ALK
ALK-IN-1 (AP26113) is a potent ALK inhibitor with IC50 of 0.62 nM in a cell-free assay, demonstrated ability overcome Crizotinib resistance mediated by a L1196M mutation. Phase 2.
T4071 Repotrectinib TPX-0005,TPX 0005,TPX0005 Trk receptor , ROS , Src , ALK , ROS Kinase
Repotrectinib (TPX-0005) is a potent ALK/ROS1/TRK inhibitor, with IC50 of 1.01 nM, 5.3 nM, 1.08 nM and 1.26 nM for WT ALK, SRC, ALK L1196M and ALK G1202R, respectively.
T1962 ASP3026 ASP 3026 Apoptosis , ALK
ASP3026 has been used in trials studying the treatment of Solid Tumor, B-Cell Lymphoma, Advanced Malignancies, Positive for Anaplastic Lymphoma Kinase, and Positive for Proto-Oncogene Tyrosine-Protein Kinase ROS.
T4015 HG-14-10-04 ALK
HG-14-10-04 is a potent and specific ALK inhibitor.
T2655 CEP-37440 CEP37440 FAK , ALK
CEP-37440 is an effective and specific Dual FAK/ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).
T1791 Ceritinib LDK378 Serine Protease , IGF-1R , ALK
Ceritinib (LDK378) is a specific ALK inhibitor (IC50: 0.2 nM).
T3621 Brigatinib AP-26113 EGFR , FLT , ROS , IGF-1R , ALK
Brigatinib (AP-26113) is a highly potent and selective ALK inhibitor.
T1661 Crizotinib PF-02341066 c-Met/HGFR , ROS , ALK , Autophagy , ROS Kinase
Crizotinib (PF-02341066) is an ATP-competitive small-molecule tyrosine kinases inhibitor of c-MET (IC50: 8 nM) and ALK (IC50: 20 nM) receptor.
T3678 Entrectinib RXDX-101,NMS-E628 Trk receptor , ROS , ALK , Autophagy , ROS Kinase
Entrectinib (RXDX-101) is an inhibitor of TrkA (IC50: 1.7 nM), TrkB (IC50: 0.1 nM), and TrkC (IC50: 0.1 nM), as well as anaplastic lymphoma kinase (ALK; IC50: 1.6 nM) and C-ros oncogene 1 (ROS1; IC50: 0.2 nM). Entrectini...
1 2
TargetMol